Nyxoah Announces CE Mark Approval for Genio® 2.1
The next generation external activation chip leverages Nyxoah’s scalable platform to continuously enhance patient comfort and therapy efficacy
Read more at globenewswire.comAll information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
Nyxoah Announces CE Mark Approval for Genio® 2.1
The next generation external activation chip leverages Nyxoah’s scalable platform to continuously enhance patient comfort and therapy efficacy
Read more at globenewswire.com